Lung cancer (Amsterdam, Netherlands), 2014-10, Vol.86 (1), p.91-95
2014
Volltextzugriff (PDF)
Details
- Autor(en) / Beteiligte
- Titel
- Prognostic role of hyponatremia in 564 small cell lung cancer patients treated with topotecan
- Ist Teil von
- Lung cancer (Amsterdam, Netherlands), 2014-10, Vol.86 (1), p.91-95
- Ort / Verlag
- Oxford: Elsevier Ireland Ltd
- Erscheinungsjahr
- 2014
- Quelle
- Access via ScienceDirect (Elsevier)
- Beschreibungen/Notizen
- Highlights • Hyponatremia is reported in about 15% of small-cell lung cancer. • Baseline clinical and laboratory data were retrospectively obtained from 564 patients. • All patients were treated with second-line intravenous topotecan. • By Cox multivariate analysis hyponatremia was associated with poorer prognosis. • Further prospective studies are needed to confirm these results.
- Sprache
- Englisch
- Identifikatoren
- ISSN: 0169-5002eISSN: 1872-8332DOI: 10.1016/j.lungcan.2014.07.022Titel-ID: cdi_proquest_miscellaneous_1564354396
- Format
- –
- Schlagworte
- Aged, Antineoplastic Agents - therapeutic use, Biological and medical sciences, Female, Hematology, Oncology and Palliative Medicine, Humans, Hyponatremia, Hyponatremia - diagnosis, Hyponatremia - etiology, Lung Neoplasms - complications, Lung Neoplasms - drug therapy, Lung Neoplasms - mortality, Lung Neoplasms - pathology, Male, Medical sciences, Middle Aged, Multiple tumors. Solid tumors. Tumors in childhood (general aspects), Neoplasm Metastasis, Neoplasm Staging, Pneumology, Prognosis, Prognostic, Pulmonary/Respiratory, Retrospective Studies, Second-line, Serum sodium (Napl), Small cell lung cancer, Small Cell Lung Carcinoma - complications, Small Cell Lung Carcinoma - drug therapy, Small Cell Lung Carcinoma - mortality, Small Cell Lung Carcinoma - pathology, Topoisomerase I Inhibitors - therapeutic use, Topotecan, Topotecan - therapeutic use, Treatment Outcome, Tumors, Tumors of the respiratory system and mediastinum